These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14739048)

  • 1. Pancreatic beta-cell defects in women at risk of type 2 diabetes.
    Pimenta WP; Rudge MV; Aragon FF; Padovani CR
    Diabetes Res Clin Pract; 2004 Feb; 63(2):87-92. PubMed ID: 14739048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical abnormalities of glucose metabolism in Brazilian women with a history of gestational diabetes mellitus.
    Pimenta WP; Calderon IM; Cruz NS; Santos ML; Aragon FF; Padovani CR
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1152-8. PubMed ID: 15548148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
    van Haeften TW; Dubbeldam S; Zonderland ML; Erkelens DW
    Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining pancreatic β-cell compensation for changing insulin sensitivity using an oral glucose tolerance test.
    Solomon TP; Malin SK; Karstoft K; Knudsen SH; Haus JM; Laye MJ; Pedersen M; Pedersen BK; Kirwan JP
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E822-9. PubMed ID: 25184989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
    Fritsche A; Stefan N; Hardt E; Häring H; Stumvoll M
    Diabetologia; 2000 Jul; 43(7):852-8. PubMed ID: 10952457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion.
    Cretti A; Lehtovirta M; Bonora E; Brunato B; Zenti MG; Tosi F; Caputo M; Caruso B; Groop LC; Muggeo M; Bonadonna RC
    Eur J Clin Invest; 2001 May; 31(5):405-16. PubMed ID: 11380592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy.
    Kautzky-Willer A; Prager R; Waldhausl W; Pacini G; Thomaseth K; Wagner OF; Ulm M; Streli C; Ludvik B
    Diabetes Care; 1997 Nov; 20(11):1717-23. PubMed ID: 9353615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
    Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
    Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene).
    Clocquet AR; Egan JM; Stoffers DA; Muller DC; Wideman L; Chin GA; Clarke WL; Hanks JB; Habener JF; Elahi D
    Diabetes; 2000 Nov; 49(11):1856-64. PubMed ID: 11078452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.
    Pimenta W; Korytkowski M; Mitrakou A; Jenssen T; Yki-Jarvinen H; Evron W; Dailey G; Gerich J
    JAMA; 1995 Jun; 273(23):1855-61. PubMed ID: 7776502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].
    Tang XF; Li H; Wang JG; Chu SL; Guo JZ; Zhu DL
    Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):735-9. PubMed ID: 15631823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbances in beta-cell function in impaired fasting glycemia.
    van Haeften TW; Pimenta W; Mitrakou A; Korytkowski M; Jenssen T; Yki-Jarvinen H; Gerich JE
    Diabetes; 2002 Feb; 51 Suppl 1():S265-70. PubMed ID: 11815491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion.
    Pimenta WP; Santos ML; Cruz NS; Aragon FF; Padovani CR; Gerich JE
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):468-76. PubMed ID: 12522327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?
    Stadler M; Anderwald C; Karer T; Tura A; Kästenbauer T; Auinger M; Bieglmayer C; Wagner O; Kronenberg F; Nowotny P; Pacini G; Prager R
    Diabetes Care; 2006 May; 29(5):1031-8. PubMed ID: 16644633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
    Bacha F; Gungor N; Lee S; Arslanian SA
    Diabetes Care; 2009 Jan; 32(1):100-5. PubMed ID: 18835946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation.
    Velho G; Byrne MM; Clément K; Sturis J; Pueyo ME; Blanché H; Vionnet N; Fiet J; Passa P; Robert JJ; Polonsky KS; Froguel P
    Diabetes; 1996 Apr; 45(4):478-87. PubMed ID: 8603770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.